FindTrial
Sign In

Treatment of intractable trigeminal neuralgia by injection of doxorubicin with CT guided foramen ovale

Treatment of intractable trigeminal neuralgia by injection of doxorubicin with CT guided foramen ovale

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014492
Enrollment
Unknown
Registered
2018-01-17
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuralgia

Interventions

Adriamycin group:Adriamycin injection
Radiofrequency group:Radiofrequency therapy

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. older than 40 years, less than 70 years old; 2. second and three were trigeminal only patients; 3. disease course no more than 1 years; 4. occupying patients, exclusion caused by secondary trigeminal neuralgia; 5. VAS score greater than 8 patients; 6. masseter muscle atrophy and other the patients with complications.

Exclusion criteria

Exclusion criteria: 1. were infected locally; 2. combined with severe organic lesions; 3. localized lesions; 4. and local muscular atrophy.

Design outcomes

Primary

MeasureTime frame
VAS;?????;—

Countries

China

Contacts

Public ContactHe Yongjin

Tianjin First Central Hospital

heyongjin1995@sina.com+86 18630810588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026